-
56901-10MGApplication Geranyl monophosphate (GP) may be used to study the kinetics and substrate specificity of modified/mutated isopentenyl phosphate kinases. Such studies may lead to engineered IPK mutants capable of facilitating the chemoenzymatic
-
19533-5MGApplication Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
-
76532-10MG
Sigma-Aldrich
Geranyl pyrophosphate lithium salt (C15-1223-121)
Price: $1,193.14List Price: $1,325.71Biochem/physiol Actions Metabolite in monoterpenoid biosynthesis, substrate for monoterpene synthases. Packaging Bottomless glass bottle. -
76532-50MG
Sigma-Aldrich
Geranyl pyrophosphate lithium salt (C15-1223-122)
Price: $4,681.32List Price: $5,201.47Biochem/physiol Actions Metabolite in monoterpenoid biosynthesis, substrate for monoterpene synthases. Packaging Bottomless glass bottle. -
474150-25MLGlycidyl 2,2,3,3-tetrafluoropropyl ether
-
G342927-5mgGlycidyl Palmitate-d5 is the deuterium labeled Glycidyl Palmitate.
-
-
900560-10MLGraphene quantum dots (GQDs) have the potential to be applied towards next generation electronics and energy applications. Graphene itself does not possess band gap energy and its usage is limited.
-
900712-50MLGraphene quantum dots (GQDs), sheets of few-layered graphene and lateral dimensions smaller than 100 nm, possess strong quantum confinement and edge effects. Thus, they possess unique physical properties such as strong photoluminescence, which can
-
900713-50MGApplication Graphene quantum dots (GQDs), sheets of few-layered graphene and lateral dimensions smaller than 100 nm, possess strong quantum confinement and edge effects. Thus, they possess unique physical properties such as strong
-
900726-50MGApplication Graphene quantum dots (GQDs), sheets of few-layered graphene and lateral dimensions smaller than 100 nm, possess strong quantum confinement and edge effects. Thus, they possess unique physical properties such as strong
-
G412960-100mgGSK121 trifluoroacetate is a selective inhibitor of PAD4.